Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VQ2N
|
|||
| Drug Name |
PMID29757691-Compound-8c
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H36N2O2
|
|||
| Canonical SMILES |
CCN(CC)CCC(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCN(CC)CC
|
|||
| InChI |
1S/C26H36N2O2/c1-5-27(6-2)19-17-25(29)23-13-9-21(10-14-23)22-11-15-24(16-12-22)26(30)18-20-28(7-3)8-4/h9-16H,5-8,17-20H2,1-4H3
|
|||
| InChIKey |
BFCHHHLQSJIBJK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Acetylcholinesterase (AChE) | Target Info | Inhibitor | [1] |
| Cholinesterase (BCHE) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Acetylcholinesterase (AChE) | Target's Patent Info | [1] | |
| Cholinesterase (BCHE) | Target's Patent Info | [1] | ||
| KEGG Pathway | Glycerophospholipid metabolism | |||
| Cholinergic synapse | ||||
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| Pathwhiz Pathway | Phospholipid Biosynthesis | |||
| Pathway Interaction Database | ATF-2 transcription factor network | |||
| WikiPathways | Irinotecan Pathway | |||
| Monoamine Transport | ||||
| Biogenic Amine Synthesis | ||||
| Acetylcholine Synthesis | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A patent review of butyrylcholinesterase inhibitors and reactivators 2010-2017.Expert Opin Ther Pat. 2018 Jun;28(6):455-465. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.